The global sales of the Blood Testing Market in 2021 were held at US$ 80.2 Bn. With a CAGR of 9.6% during 2022 - 2032, the market is projected to reach a valuation of US$ 218.2 Bn.
The market through Glucose tests is expected to be the highest revenue-generating segment, which is projected to grow at a CAGR of over 10.7% during 2022 – 2032.
As per the Blood Testing Market research by Transparency Market Research - a market research and competitive intelligence provider, historically, from 2015 to 2021, the market value of Blood Testing increased by around 8.7% CAGR.
To stay up with the development of newer technologies that combine the precision of lab testing with the convenience of self-monitoring, point-of-care testing is on the rise.
Blood tests are being developed that could lead to significant advances in the study of infections, such as assays that can detect a wide range of diseases and cancers from a single drop of blood. Due to higher sales of COVID-19 tests than tests for other indications, during COVID-19 the market for blood testing surged significantly.
The increased use of at-home glucose tests is predicted to raise market revenue, making it one of the top three testing segments. The increased prevalence of Type 1 and Type 2 diabetes, as well as the rising risk of hereditary diabetes, can be related to this increase.
Furthermore, diabetes monitoring is required prior to any surgical procedure, causing this segment's demand to skyrocket. The segment's expansion is further aided by the availability of reusable and user-friendly glucose monitoring meters.
A motivating force is the growing number of blood donations from all across the world. Donated blood is in high demand due to the availability and needs for advanced surgical procedures such as cardiovascular and transplant surgery, trauma treatment, and cancer and blood disease therapies.
Emerging regions such as India, the Middle East, and Africa provide attractive opportunities for blood screening industry players due to increased disposable incomes and improved healthcare infrastructure.
The primary growth drivers of the blood-testing sector are the large rise in chronic diseases and the growing awareness of the global population toward their self-health. The growing number of persons sick with pathogens will provide the sector with a strong boost.
The market will be driven by an increase in chronic illnesses combined with health evaluations. Furthermore, the rising prevalence of infectious disorders such as diabetes, COVID-19, and cardiovascular diseases is likely to drive market growth.
Furthermore, as the number of cancer patients grows, so does the demand for blood donations. Cancer patients require blood and platelets during chemotherapy, blood replacement, and surgery. As a result, the need for screening tests is projected to rise.
However, the market's expansion is being hampered by a lengthy regulatory approval process. The FDA, for example, is in charge of approving the use of clinical laboratory tests. In addition, a lack of understanding regarding the development of new blood testing technologies and processes is limiting the market growth.
In 2021, North America held the largest share of the global market. Technological advancements such as the introduction of miniaturized diagnostic devices, which provide rapid and accurate test results and have higher market penetration in the region, as well as favorable medical insurance policies, improved healthcare infrastructure, and new government programs, are helping to drive development.
The dense population of India and China, where the necessity for frequent check-ups is growing due to an increase in ailments like cancer, diabetes, and liver disease, among others, is supporting Asia Pacific's blood testing market expansion.
The United States is expected to account for the largest market share of US$ 84.3 Bn by the end of 2032. The plaintiffs of healthcare companies have benefited from favorable government policies as well as favorable insurance policies. There has been a constant improvement in the technologies which have high penetration capabilities, leading to market growth in the US.
The market in the U.K. is expected to reach US$ 8.7 Bn by 2032. Growing at a CAGR of 10.5% during the forecast period, the market in the country is expected to gross an absolute dollar opportunity of US$ 5.4 Bn.
The glucose testing segment is forecasted to grow at the highest CAGR of over 10.7% during 2022-2032. The glucose testing sector is expected to dominate the market throughout the forecast period due to the rising number of diabetic patients and changing lifestyles. Blood glucose levels are measured in both laboratories and at the point of care.
Diabetes is becoming a significant burden worldwide as the frequency of the disease rises. It is one of the most common causes of death in the United States. Early detection and regular monitoring can help to enhance illness treatment and control. Because of the aging population, glucose testing has become more popular in recent years.
Some of the important drivers driving the growth of the glucose testing market include an increase in the obese population, an increase in lifestyle-related disorders, and an increase in the prevalence of diabetes. Furthermore, rising healthcare awareness is propelling the glucose testing market forward.
In 2021, the blood banks and hospitals sector accounted for the largest proportion of the market by the end user. There are two types of blood screening setups: blood banks and hospitals. In 2021, the blood banks category accounted for the largest share of the blood screening market. This segment's growth is being fuelled by rising demand for blood donations as well as an increase in the number of organ transplant surgeries.
Some of the key players in the blood testing industry include Abbott Laboratories, Beckman Coulter, Nanosphere Inc., Beckton Dickinson and Company, Bruker Corporation, Trinity Biotech Plc., Bio-Rad Laboratories, and Biomerica Inc.
Some of the recent developments of key blood testing providers are as follows:
Similarly, recent developments related to companies in the Blood Testing business have been tracked by the team at Transparency Market Research, which is available in the full report.
By Type
By End User
By Region
|
Attribute |
Details |
|
Global Market (2022) |
US$ 87.5 Bn |
|
Global Blood Testing Industry (2032) |
US$ 218.2 Bn |
|
Global Market CAGR (2022 – 2032) |
9.6% |
|
U.S. Blood Testing Market CAGR (2022 – 2032) |
10.1% |
|
Key Companies Profiled |
|
The global market is worth more than US$ 80.2 Bn at present.
The market value is projected to increase at a CAGR of around 9.6% during 2022 – 2032.
The market value increased at a CAGR of around 8.7% during 2015 – 2021.
The aging population, a large increase in chronic diseases, and the strategic development in technology and infrastructure are bolstering growth.
The market for Blood Testing in China is projected to expand at a CAGR of around 11.4% during 2022 – 2032.
While the market in South Korea is expected to grow at nearly 7.0%, the market in Japan is projected to register a CAGR of nearly 10.8% during 2022 - 2032.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Investment Feasibility Matrix
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Blood Testing Market Analysis 2015-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2015-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Blood Testing Market Analysis 2015-2021 and Forecast 2022-2032, By Test Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Test Type, 2015-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Test Type, 2022-2032
5.3.1. Glucose
5.3.2. A1C
5.3.3. Direct LDL
5.3.4. Lipid panel
5.3.5. Prostate-specific antigen
5.3.6. COVID-19
5.3.7. Bun testing
5.3.8. Vitamin D
5.3.9. Testosterone
5.3.10. ALT
5.3.11. Creatinine
5.3.12. Other Test Types
5.4. Y-o-Y Growth Trend Analysis By Test Type, 2015-2021
5.5. Absolute $ Opportunity Analysis By Test Type, 2022-2032
6. Global Blood Testing Market Analysis 2015-2021 and Forecast 2022-2032, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2015-2021
6.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa
6.4. Market Attractiveness Analysis By Region
7. North America Blood Testing Market Analysis 2015-2021 and Forecast 2022-2032, By Country
7.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
7.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
7.2.1. By Country
7.2.1.1. U.S.
7.2.1.2. Canada
7.2.2. By Test Type
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By Test Type
7.4. Key Takeaways
8. Latin America Blood Testing Market Analysis 2015-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Rest of Latin America
8.2.2. By Test Type
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Test Type
8.4. Key Takeaways
9. Europe Blood Testing Market Analysis 2015-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. U.K.
9.2.1.3. France
9.2.1.4. Spain
9.2.1.5. Italy
9.2.1.6. Russia
9.2.1.7. Rest of Europe
9.2.2. By Test Type
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Test Type
9.4. Key Takeaways
10. Asia Pacific Blood Testing Market Analysis 2015-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. China
10.2.1.2. Japan
10.2.1.3. India
10.2.1.4. South Korea
10.2.1.5. Australia
10.2.1.6. Rest of APAC
10.2.2. By Test Type
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Test Type
10.4. Key Takeaways
11. Middle East and Africa Blood Testing Market Analysis 2015-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. South Africa
11.2.1.2. Saudi Arabia
11.2.1.3. UAE
11.2.1.4. Israel
11.2.1.5. Rest of MEA
11.2.2. By Test Type
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Test Type
11.4. Key Takeaways
12. Key Countries Blood Testing Market Analysis
12.1. U.S.
12.1.1. Pricing Analysis
12.1.2. Market Share Analysis, 2021
12.1.2.1. By Test Type
12.2. Canada
12.2.1. Pricing Analysis
12.2.2. Market Share Analysis, 2021
12.2.2.1. By Test Type
12.3. Brazil
12.3.1. Pricing Analysis
12.3.2. Market Share Analysis, 2021
12.3.2.1. By Test Type
12.4. Mexico
12.4.1. Pricing Analysis
12.4.2. Market Share Analysis, 2021
12.4.2.1. By Test Type
12.5. Germany
12.5.1. Pricing Analysis
12.5.2. Market Share Analysis, 2021
12.5.2.1. By Test Type
12.6. U.K.
12.6.1. Pricing Analysis
12.6.2. Market Share Analysis, 2021
12.6.2.1. By Test Type
12.7. France
12.7.1. Pricing Analysis
12.7.2. Market Share Analysis, 2021
12.7.2.1. By Test Type
12.8. Spain
12.8.1. Pricing Analysis
12.8.2. Market Share Analysis, 2021
12.8.2.1. By Test Type
12.9. Italy
12.9.1. Pricing Analysis
12.9.2. Market Share Analysis, 2021
12.9.2.1. By Test Type
12.10. Russia
12.10.1. Pricing Analysis
12.10.2. Market Share Analysis, 2021
12.10.2.1. By Test Type
12.11. China
12.11.1. Pricing Analysis
12.11.2. Market Share Analysis, 2021
12.11.2.1. By Test Type
12.12. Japan
12.12.1. Pricing Analysis
12.12.2. Market Share Analysis, 2021
12.12.2.1. By Test Type
12.13. India
12.13.1. Pricing Analysis
12.13.2. Market Share Analysis, 2021
12.13.2.1. By Test Type
12.14. South Korea
12.14.1. Pricing Analysis
12.14.2. Market Share Analysis, 2021
12.14.2.1. By Test Type
12.15. Australia
12.15.1. Pricing Analysis
12.15.2. Market Share Analysis, 2021
12.15.2.1. By Test Type
12.16. South Africa
12.16.1. Pricing Analysis
12.16.2. Market Share Analysis, 2021
12.16.2.1. By Test Type
12.17. Saudi Arabia
12.17.1. Pricing Analysis
12.17.2. Market Share Analysis, 2021
12.17.2.1. By Test Type
12.18. UAE
12.18.1. Pricing Analysis
12.18.2. Market Share Analysis, 2021
12.18.2.1. By Test Type
12.19. Israel
12.19.1. Pricing Analysis
12.19.2. Market Share Analysis, 2021
12.19.2.1. By Test Type
13. Market Structure Analysis
13.1. Competition Dashboard
13.2. Competition Benchmarking
13.3. Market Share Analysis of Top Players
13.3.1. By Regional
13.3.2. By Test Type
14. Competition Analysis
14.1. Competition Deep Dive
14.1.1. Abbott
14.1.1.1. Overview
14.1.1.2. Product Portfolio
14.1.1.3. Profitability by Market Segments
14.1.1.4. Sales Footprint
14.1.1.5. Strategy Overview
14.1.1.5.1. Marketing Strategy
14.1.2. F. Hoffmann-La Roche AG
14.1.2.1. Overview
14.1.2.2. Product Portfolio
14.1.2.3. Profitability by Market Segments
14.1.2.4. Sales Footprint
14.1.2.5. Strategy Overview
14.1.2.5.1. Marketing Strategy
14.1.3. Bio-Rad Laboratories, Inc.
14.1.3.1. Overview
14.1.3.2. Product Portfolio
14.1.3.3. Profitability by Market Segments
14.1.3.4. Sales Footprint
14.1.3.5. Strategy Overview
14.1.3.5.1. Marketing Strategy
14.1.4. BioMerieux SA
14.1.4.1. Overview
14.1.4.2. Product Portfolio
14.1.4.3. Profitability by Market Segments
14.1.4.4. Sales Footprint
14.1.4.5. Strategy Overview
14.1.4.5.1. Marketing Strategy
14.1.5. Quest Diagnostics
14.1.5.1. Overview
14.1.5.2. Product Portfolio
14.1.5.3. Profitability by Market Segments
14.1.5.4. Sales Footprint
14.1.5.5. Strategy Overview
14.1.5.5.1. Marketing Strategy
14.1.6. Biomerica, Inc.
14.1.6.1. Overview
14.1.6.2. Product Portfolio
14.1.6.3. Profitability by Market Segments
14.1.6.4. Sales Footprint
14.1.6.5. Strategy Overview
14.1.6.5.1. Marketing Strategy
14.1.7. Becton, Dickinson and Company
14.1.7.1. Overview
14.1.7.2. Product Portfolio
14.1.7.3. Profitability by Market Segments
14.1.7.4. Sales Footprint
14.1.7.5. Strategy Overview
14.1.7.5.1. Marketing Strategy
14.1.8. Siemens Healthineers
14.1.8.1. Overview
14.1.8.2. Product Portfolio
14.1.8.3. Profitability by Market Segments
14.1.8.4. Sales Footprint
14.1.8.5. Strategy Overview
14.1.8.5.1. Marketing Strategy
14.1.9. Danaher Corporation
14.1.9.1. Overview
14.1.9.2. Product Portfolio
14.1.9.3. Profitability by Market Segments
14.1.9.4. Sales Footprint
14.1.9.5. Strategy Overview
14.1.9.5.1. Marketing Strategy
14.1.10. Trinity Biotech Plc
14.1.10.1. Overview
14.1.10.2. Product Portfolio
14.1.10.3. Profitability by Market Segments
14.1.10.4. Sales Footprint
14.1.10.5. Strategy Overview
14.1.10.5.1. Marketing Strategy
15. Assumptions & Acronyms Used
16. Research Methodology
List of Tables
Table 1: Global Blood Testing Market Value (US$ Mn) Forecast by Region, 2015-2032
Table 2: Global Blood Testing Market Value (US$ Mn) Forecast by Test Type, 2015-2032
Table 3: North America Blood Testing Market Value (US$ Mn) Forecast by Country, 2015-2032
Table 4: North America Blood Testing Market Value (US$ Mn) Forecast by Test Type, 2015-2032
Table 5: Latin America Blood Testing Market Value (US$ Mn) Forecast by Country, 2015-2032
Table 6: Latin America Blood Testing Market Value (US$ Mn) Forecast by Test Type, 2015-2032
Table 7: Europe Blood Testing Market Value (US$ Mn) Forecast by Country, 2015-2032
Table 8: Europe Blood Testing Market Value (US$ Mn) Forecast by Test Type, 2015-2032
Table 9: Asia Pacific Blood Testing Market Value (US$ Mn) Forecast by Country, 2015-2032
Table 10: Asia Pacific Blood Testing Market Value (US$ Mn) Forecast by Test Type, 2015-2032
Table 11: Middle East and Africa Blood Testing Market Value (US$ Mn) Forecast by Country, 2015-2032
Table 12: Middle East and Africa Blood Testing Market Value (US$ Mn) Forecast by Test Type, 2015-2032
List of Figures
Figure 1: Global Blood Testing Market Value (US$ Mn) by Test Type, 2022-2032
Figure 2: Global Blood Testing Market Value (US$ Mn) by Region, 2022-2032
Figure 3: Global Blood Testing Market Value (US$ Mn) Analysis by Region, 2015-2032
Figure 4: Global Blood Testing Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 5: Global Blood Testing Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 6: Global Blood Testing Market Value (US$ Mn) Analysis by Test Type, 2015-2032
Figure 7: Global Blood Testing Market Value Share (%) and BPS Analysis by Test Type, 2022-2032
Figure 8: Global Blood Testing Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032
Figure 9: Global Blood Testing Market Attractiveness by Test Type, 2022-2032
Figure 10: Global Blood Testing Market Attractiveness by Region, 2022-2032
Figure 11: North America Blood Testing Market Value (US$ Mn) by Test Type, 2022-2032
Figure 12: North America Blood Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 13: North America Blood Testing Market Value (US$ Mn) Analysis by Country, 2015-2032
Figure 14: North America Blood Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 15: North America Blood Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 16: North America Blood Testing Market Value (US$ Mn) Analysis by Test Type, 2015-2032
Figure 17: North America Blood Testing Market Value Share (%) and BPS Analysis by Test Type, 2022-2032
Figure 18: North America Blood Testing Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032
Figure 19: North America Blood Testing Market Attractiveness by Test Type, 2022-2032
Figure 20: North America Blood Testing Market Attractiveness by Country, 2022-2032
Figure 21: Latin America Blood Testing Market Value (US$ Mn) by Test Type, 2022-2032
Figure 22: Latin America Blood Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 23: Latin America Blood Testing Market Value (US$ Mn) Analysis by Country, 2015-2032
Figure 24: Latin America Blood Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 25: Latin America Blood Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 26: Latin America Blood Testing Market Value (US$ Mn) Analysis by Test Type, 2015-2032
Figure 27: Latin America Blood Testing Market Value Share (%) and BPS Analysis by Test Type, 2022-2032
Figure 28: Latin America Blood Testing Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032
Figure 29: Latin America Blood Testing Market Attractiveness by Test Type, 2022-2032
Figure 30: Latin America Blood Testing Market Attractiveness by Country, 2022-2032
Figure 31: Europe Blood Testing Market Value (US$ Mn) by Test Type, 2022-2032
Figure 32: Europe Blood Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 33: Europe Blood Testing Market Value (US$ Mn) Analysis by Country, 2015-2032
Figure 34: Europe Blood Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 35: Europe Blood Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 36: Europe Blood Testing Market Value (US$ Mn) Analysis by Test Type, 2015-2032
Figure 37: Europe Blood Testing Market Value Share (%) and BPS Analysis by Test Type, 2022-2032
Figure 38: Europe Blood Testing Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032
Figure 39: Europe Blood Testing Market Attractiveness by Test Type, 2022-2032
Figure 40: Europe Blood Testing Market Attractiveness by Country, 2022-2032
Figure 41: Asia Pacific Blood Testing Market Value (US$ Mn) by Test Type, 2022-2032
Figure 42: Asia Pacific Blood Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 43: Asia Pacific Blood Testing Market Value (US$ Mn) Analysis by Country, 2015-2032
Figure 44: Asia Pacific Blood Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 45: Asia Pacific Blood Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 46: Asia Pacific Blood Testing Market Value (US$ Mn) Analysis by Test Type, 2015-2032
Figure 47: Asia Pacific Blood Testing Market Value Share (%) and BPS Analysis by Test Type, 2022-2032
Figure 48: Asia Pacific Blood Testing Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032
Figure 49: Asia Pacific Blood Testing Market Attractiveness by Test Type, 2022-2032
Figure 50: Asia Pacific Blood Testing Market Attractiveness by Country, 2022-2032
Figure 51: Middle East and Africa Blood Testing Market Value (US$ Mn) by Test Type, 2022-2032
Figure 52: Middle East and Africa Blood Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 53: Middle East and Africa Blood Testing Market Value (US$ Mn) Analysis by Country, 2015-2032
Figure 54: Middle East and Africa Blood Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 55: Middle East and Africa Blood Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 56: Middle East and Africa Blood Testing Market Value (US$ Mn) Analysis by Test Type, 2015-2032
Figure 57: Middle East and Africa Blood Testing Market Value Share (%) and BPS Analysis by Test Type, 2022-2032
Figure 58: Middle East and Africa Blood Testing Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032
Figure 59: Middle East and Africa Blood Testing Market Attractiveness by Test Type, 2022-2032
Figure 60: Middle East and Africa Blood Testing Market Attractiveness by Country, 2022-2032
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Blood Testing Market
*86 figures and 60 tables includes